Guest Contributor


Organizations:
CTI Life Sciences, Ontario Emerging Technologies Fund, QIAGEN NV, and Xagenic Inc

Xagenic closes $10-million financing round

Guest Contributor
February 3, 2012

Toronto-based Xagenic Inc has closed a syndicated Series A financing for $10 million to develop new technology for rapid diagnostic testing. Funding for the privately held molecular diagnostics firm was provided by CTI Life Sciences, Ontario Emerging Technologies Fund and QIAGEN NV. The financing follows a $2.2-million seed round in 2010 led by MaRS Innovation. The company's testing platform will be used in hospitals, clinics and physicians' offices....


Other News

WD funds new Composites Research Network

New aerospace R&D facility established in Winnipeg

UWO re-branded as Western University

Two home-grown tech firms sold to US companies






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.